Search

everythinglearnresearchcommunity

for

Search:↓

3α-AdiolG is a good marker for androgen activity in women with excessive hair growth and decreases with anti-androgen treatment.

The anterior pituitary controls adrenal cortex size and activity through ACTH.

A woman's rare adrenal tumor caused high testosterone and cortisol levels, which normalized after the tumor was removed.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and budesonide, which improved after stopping the medications.

Human adrenals and gonads have a unique enzyme for steroid hormone production.

Scientists improved an enzyme to better produce a hair growth-promoting chemical from an immunosuppressant.

Melatonin may help reduce the needed dose of prednisolone and improve hair growth in alopecia areata patients.

Topical tacalcitol can treat psoriasis by acting directly on skin cells.

Stress increases neurosteroids that help prevent seizures.

Topical tacrolimus reduces certain growth factors in hair follicles.

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.

Pharmacists are key in choosing and guiding the safe use of topical corticosteroids for skin conditions.

Corticosteroid therapy reduces specific immune cells and promotes hair growth in alopecia areata patients.

High-dose corticosteroids can significantly regrow hair in severe alopecia areata.

Cyclosporin promotes hair growth by boosting cell growth and reducing cell death.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

Corticosteroid pulse therapy is more effective for severe alopecia areata than combination therapy.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

24-Hydroxycholesterol reduces DHT formation in brain cancer cells, linking cholesterol and hormone metabolism.

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Women with PCOS have higher 5alpha-reductase activity, affecting steroid levels.

Incorrect injection of corticosteroids for alopecia areata can cause skin problems.

Intradermal testing can better detect corticosteroid allergies than patch testing.

Androstanediol glucuronide is a reliable marker for hirsutism in women.